Clinical Trial Update: COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir [Phase 3]

View source ↗

Summary

Clinical trial update for a Phase 3 COVID-19 ring-based prevention study using lopinavir/ritonavir; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infections

Drugs mentioned

• Lopinavir/ritonavir (lopinavir/ritonavir)

Snippet

Sponsor: Unity Health Toronto | Conditions: Coronavirus Infections, Post-exposure Prophylaxis | Phase 3 | Status: UNKNOWN